Open AccessMetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway
Author(s) -
Ramon Andrade De Mello,
Pedro Nazareth Aguiar,
Hakaru Tadokoro,
Tállita Meciany Farias-Vieira,
Pedro CasteloBranco,
Gilberto Lopes,
Daniel Humberto Pozza
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.04.122
Subject(s) - pi3k/akt/mtor pathway , medicine , biomarker , protein kinase b , lung cancer , cancer research , cell , signal transduction , oncology , microbiology and biotechnology , biology , biochemistry